Difference between revisions of "Safe and Effective Drug Act"
From Wiki Weed
(Created page with "The Safe and Effective Drug Act was a bill introduced by U.S. Representative Mark Souder on December 6, 2004. It called for the National Institute on Drug Abuse to conduct a "...") |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
| − | The Safe and Effective Drug Act was a bill introduced by U.S. Representative Mark Souder on December 6, 2004. It called for the National Institute on Drug Abuse to conduct a "meta-analysis of the available scientific data regarding the safety and health risks of smoking marijuana and the clinically-proven effectiveness of smoking [[marijuana]] for medicinal purposes." The bill was criticized for centering on smoking[[ marijuana]] rather than other methods of ingestion; for calling for the analysis to be conducted by NIDA; for having a short turnaround time (120 days); and for not requiring any new research.The bill died in committee. | + | The '''Safe and Effective Drug Act''' was a bill introduced by U.S. Representative Mark Souder on December 6, 2004. It called for the [[National Institute on Drug Abuse]] to conduct a "meta-analysis of the available scientific data regarding the safety and health risks of smoking [[marijuana]] and the clinically-proven effectiveness of smoking [[marijuana]] for medicinal purposes." The bill was criticized for centering on smoking[[ marijuana]] rather than other methods of ingestion; for calling for the analysis to be conducted by NIDA; for having a short turnaround time (120 days); and for not requiring any new research.The bill died in committee. |
Latest revision as of 12:43, 9 March 2015
The Safe and Effective Drug Act was a bill introduced by U.S. Representative Mark Souder on December 6, 2004. It called for the National Institute on Drug Abuse to conduct a "meta-analysis of the available scientific data regarding the safety and health risks of smoking marijuana and the clinically-proven effectiveness of smoking marijuana for medicinal purposes." The bill was criticized for centering on smoking marijuana rather than other methods of ingestion; for calling for the analysis to be conducted by NIDA; for having a short turnaround time (120 days); and for not requiring any new research.The bill died in committee.
